SOD1 and epilepsy: The PIL group in the current study exhibited a disruption of the brain antioxidant system, which was considerably alleviated by (-) pseudosemiglabrin pretreatment, with considerable mitigation of epilepsy-induced reductions in SOD activity and GSH level.